Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 2863 record(s)

Req # A-2021-000993

Adverse Drug Reaction (ADR) for MORPHINE. Report number: E2B_04186461. ADRs for HYDROMORPHONE. Report numbers: 000950415, 000950520, E2B_04175194. ADR for HEPARIN. Report number: 000950543. ADRs for MIDAZOLAM. Report number: 000949299, 000950317, 000952239.

Organization: Health Canada

73 page(s)
December 2021

Req # A-2021-001004

Adverse Drug Reaction (ADR) for DANAZOL. Report number: E2B_03717418.

Organization: Health Canada

11 page(s)
December 2021

Req # A-2021-001005

Adverse Drug Reaction (ADR) for PREDNISOLONE. Report number: E2B_03992765.

Organization: Health Canada

33 page(s)
December 2021

Req # A-2021-001009

Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: E2B_04084422.

Organization: Health Canada

36 page(s)
December 2021

Req # A-2021-001025

Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_03841049.

Organization: Health Canada

42 page(s)
December 2021

Req # A-2021-001033

Adverse Drug Reaction (ADR) for BISACODYL. Report number: E2B_03838805.

Organization: Health Canada

55 page(s)
December 2021

Req # A-2021-001037

Adverse Drug Reaction (ADR). Report number: E2B_04198371.

Organization: Health Canada

29 page(s)
December 2021

Req # A-2021-001038

Adverse Drug Reactions (ADRs). Report numbers: E2B_03367565, E2B_03212186, E2B_03367571, E2B_03374361, E2B_03377397, E2B_03340029, E2B_03346589, E2B_03352501, E2B_03359452, E2B_03414947, E2B_03416797, E2B_03458418, E2B_03433496.

Organization: Health Canada

500 page(s)
December 2021

Req # A-2021-001048

Adverse Drug Reaction (ADR) for TRIAMCINOLONE ACETONIDE. Report number: E2B_03676035.

Organization: Health Canada

255 page(s)
December 2021

Req # A-2021-001057

Adverse Drug Reactions (ADRs) for IRBESARTAN. Report numbers: 000929982, 000946455, E2B_03587630, E2B_03567030, E2B_03587638.

Organization: Health Canada

76 page(s)
December 2021
Date modified: